Clinical Trial Update: Sphenopalatine Nerve Block for Headache Tx360 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results are reported for the sphenopalatine nerve block device (Tx360) used to treat headache and migraine, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Migraine

Snippet

Sponsor: Indiana University | Conditions: Headache, Migraine | Phase 3 | Status: COMPLETED | Results posted: 2015-07-27